Glycoproteins of Venezuelan Equine Encephalitis (VEE) Virus: Molecular Structure and Function in Virus Pathogenicity and Host Immunity

  • Dennis W. Trent
  • John T. Roehrig
  • John R. Bell
  • James H. Mathews
  • Richard M. Kinney
  • James H. Strauss
Part of the Developments in Molecular Virology book series (DMVI, volume 3)


The VEE virus particle contains a ssRNA genome enclosed in an icosahedral capsid and an envelope containing two glycoproteins, E2 (56k daltons, gpF6) and El (50k daltons, gp50). The amino terminal sequences of the envelope proteins have been determined and compared with data for other alphaviruses. The alphavirus glycoproteins share regions of homology, particularly in the conservation of proline and cysteine residues, implying that the three dimensional conformation is conserved. Deletions and amino acid replacements can occur at most locations with the alphavirus glycoproteins indicating that variation within the proteins can be accommodated without destroying biological function. Tryptic map analysis of the two virus glycoproteins shows differing degrees of diversity within the VEE complex, the larger protein being the more variable. Viral neutralization (N) and hemagglutination inhibition (HAI) determinants have been placed on the gp56 VEE/TC-83 protein using monoclonal antibody to purified proteins. Antigenic analysis indicates the presence of at least three antigenic epitopes on gp56 and four on gp50. Biological functions of N and HAI are primarily associated with gp56°, the critical N site. In vivo protection from virus infection is provided by passive immunization with antisera to gp56 and gp50 as well as highly avid monoclonal antibodies to gp56c, gp50b, gp50c, and gp50d. Small amounts c of gp56c antibodies were needed to provide protection, whereas less avid antibodies to other determinants on gp56 and gp50 were less protective. Protection from VEE virus infection appears to be determined by the specificity of antibody to the virion glycoprotein epitope, avidity of the antibody and the ability of the antibody to react with antigenic epitopes proximal to the critical N site.


Envelope Glycoprotein Antigenic Epitope Venezuelan Equine Encephalitis Virus Venezuelan Equine Encephalitis Eastern Equine Encephalitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kubes, V. and Rios, F.A. Science 90: 20–21, 1939.PubMedCrossRefGoogle Scholar
  2. 2.
    Young, N. and Johnson, K.M. Am. J. Epidemiol. 89: 386–307, 1969.Google Scholar
  3. 3.
    Shope, R.E., Causey, O.R., DeAndrade, A.H.P. and Theiler, M. Amer. J. Trop. Med. Hyg. 13: 723–727, 1964.Google Scholar
  4. 4.
    Lord, R. Bull. Pan Amer. Hlth. Org. 8: 100–110, 1974.Google Scholar
  5. 5.
    Yershov, F.I., Sokolova, T.M. and Titenko, A.M. Acta Virol. 21: 213–221, 1977.PubMedGoogle Scholar
  6. 6.
    Mussgay, M. and Weibel, J. Virology 16: 52–62, 1962.PubMedCrossRefGoogle Scholar
  7. 7.
    Pederson, C.E., Jr. and Eddy, G.A. J. Virol. 14: 740–744, 1974.Google Scholar
  8. 8.
    France, J.K., Wyrick, B.C. Trent, D.W. J. Gen. Virol. 44: 725–740, 1979.PubMedCrossRefGoogle Scholar
  9. 9.
    Kinney, R.M., Trent, D.W. and France, J.K. J. Gen. Virol. 64:135– 147.Google Scholar
  10. 10.
    Roehrig, J.T., Day, J.W. and Kinney, R.M. Virology 118: 269–279, 1982.PubMedCrossRefGoogle Scholar
  11. 11.
    Mathews, J.H. and Roehrig, J.T. J. Immuno. 129: 2763–2767.Google Scholar
  12. 12.
    Compans, R.W. Nature 229: 114–116, 1971.Google Scholar
  13. 13.
    Dalyrmple, J.M., Teramoto, A.Y., Cardiff, R.D. and Russell, P.K. J. Immunol. 109: 426–433, 1972.Google Scholar
  14. 14.
    Dalyrmple, J.M., Vogel, S.N., Teramoto, A.Y. and Russell, P.K. J. Virol. 12: 1034–1042, 1973.Google Scholar
  15. 15.
    Trent, D.W., Clewley, J.P., France, J.K. and Bishop, D.H.L. J. Gen. Virol. 47: 261–282, 1979.CrossRefGoogle Scholar
  16. 16.
    Laemmli, U.K. Nature 227: 680–685, 1970.PubMedCrossRefGoogle Scholar
  17. 17.
    Kinnev, R.M. and Trent, D.W. Virology 121: 345–362, 1981.CrossRefGoogle Scholar
  18. 18.
    Hunkapiller, M.W. and Hood, L.E. Science 207: 523–525, 1980.PubMedCrossRefGoogle Scholar
  19. Bell, J.R., Hunkapiller, M.W., Hood, K.E., and Strauss, J.H. Proc. Natl. Acad. Sci. U.S.A. 75: 2722–2726, 1978.PubMedCrossRefGoogle Scholar
  20. 20.
    Rice, C.M. and Strauss, J.H. J. Mol. Biol. 150: 315–340, 1981.CrossRefGoogle Scholar
  21. 21.
    Garoff, H., Frichauf, A.-M., Simons, K., Lehrach, H. and Delius, H. Nature 288: 236–241, 1980.PubMedCrossRefGoogle Scholar
  22. 22.
    Bell, J.R., Bond, M.W., Hunkapiller, M.W., Straus, E.G., Strauss, J.H., Yamamoto, K. and Simiza, B. J. Virol. 45:708–714., 1982.Google Scholar
  23. 23.
    Schlesinger, M.J. and Kaariainen, L. In: The Togaviruses (Ed. R.W. Schlesinger ), Academic Press, Inc., 1980, pp. 371–392.Google Scholar
  24. 24.
    Wiley, D.C., Wilson, I.A. and Skehel, J.J. Nature 289: 373–378, 1981.PubMedCrossRefGoogle Scholar
  25. 25.
    Mecham, J.O. and Trent, D.W. Virology 121: 251–261, 1982.PubMedCrossRefGoogle Scholar
  26. 26.
    Pedersen, C.E. and Eddy, G.A. J. Virol. 14: 740–744, 1974.PubMedGoogle Scholar
  27. 27.
    Calisher, C.H., Shope, R.E., Brandt, W., Casals, J., Karabatsos, N., Murphy, F.A., Tesh, R.B., and Wiebe, M.E. Intervirol. 14: 229–232, 1980.CrossRefGoogle Scholar
  28. 28.
    Cancedda, R., Villa-Komaroff, L., Lodish, H.F. and Schlesinger, M. Cell 6: 215–222, 1975.PubMedCrossRefGoogle Scholar
  29. 29.
    Wengler, G., Wengler, G. and Filipe, A.R. Virology 78: 124–134, 1977.PubMedCrossRefGoogle Scholar
  30. 30.
    Rentier-Del rue, F. and Young, N.A. Virology 106: 59–70, 1980.CrossRefGoogle Scholar
  31. 31.
    Trent, D.W. and Grant, J.A. J. Gen. Virol. 43: 365–381, 1980.CrossRefGoogle Scholar
  32. 32.
    Massey, R.J. and Schochetman, G. Virology 115: 20–32, 1981.PubMedCrossRefGoogle Scholar
  33. 33.
    Cooper, N.R. In: Comprehensive Virology (Eds. H. Fraenkel-Conrat and R.R. Wagner ), Plenum, N.Y., 1979, pp. 123–158.CrossRefGoogle Scholar
  34. 34.
    Chanas, A.C., Gould, E.A., Clegg, J.C.S., and Varma, M.G.R. J. Gen. Virol. 58: 37–46, 1982.PubMedCrossRefGoogle Scholar
  35. 35.
    Schmaljohn, A.L., Johnson, E.D., Dalrymple, J.M. and Cole, G.A. Nature 297: 70–72, 1982.PubMedCrossRefGoogle Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • Dennis W. Trent
    • 1
  • John T. Roehrig
    • 1
  • John R. Bell
    • 2
  • James H. Mathews
    • 1
  • Richard M. Kinney
    • 1
  • James H. Strauss
    • 2
  1. 1.Division of Vector-Borne Viral DiseasesCenters for Disease ControlFort CollinsUSA
  2. 2.Division of BiologyCalifornia Institute of TechnologyPasadenaUSA

Personalised recommendations